SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as the community discusses the appointment of Kaz Nejatian, former COO of Shopify, as the new CEO, and the return of co-founders Keith Rabois and Eric Wu to the Board.  The news is sparking excitement and speculation about the company's future direction, with many anticipating a potential short squeeze and a shift towards an AI-first real estate platform.  Overall, the leadership changes are seen as a positive catalyst, injecting fresh energy and expertise into the company.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid heated online discussions, with community members expressing strong opinions and political views. The catalyst appears to be an incident involving political violence, sparking debates about freedom of speech, gun control, and the current political climate. The conversation also touches on broader themes, including social division, extremist ideologies, and the role of political leaders in shaping public discourse.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending amid reports of a shooting involving conservative figure Charlie Kirk, sparking heated debate and political commentary within the community. Discussions range from the implications of political violence to gun control and broader societal divisions. The incident occurs ahead of CPI data, adding another layer of uncertainty to the market's direction.

Armada Acquisition Corp. I operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was founded on November 5, 2020 and is headquartered in Philadelphia, PA.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI ($RZLV) is trending amid increasing investor enthusiasm and high trading volume, with the community actively discussing the potential for significant growth and ARR. Positive sentiment is fueled by the CEO's proactive approach and upcoming earnings report, leading to speculation about a continued surge. Some investors suggest the stock is undervalued compared to its AI peers, contributing to the bullish outlook.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to a recently filed $300M mixed securities shelf, leading to community debate about potential dilution and the company's financial strategy. Some investors express concern over increasing expenses and the need for funding, while others believe the shelf registration is a strategic move to capitalize on market movements. Amidst the uncertainty, there's discussion around upcoming FDA meeting minutes and their potential impact on the company's regulatory path for its lead drug candidate.

Wearable Devices Ltd. engages in the development of a non-invasive neural input technology that allows operation and control of digital devices using subtle finger movements and fingertip pressure. It offers Mudra band, a neutral input wristband. The company was founded by Asher Dahan, Guy Wagner, and Leeor Langer in March 2014 and is headquartered in Yokne'am Illit, Israel.

Wearable Devices Ltd

WLDS is trending due to a recently granted patent for voice and gesture control technology, sparking discussions about potential acquisitions from major tech players like Apple and Meta. Community members are actively debating the stock's valuation, potential buyout prices, and likelihood of a short squeeze, while also weighing the risks of dilution and historical stock behavior. The stock's low float and high volatility are contributing to the intense interest and trading activity.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is trending amid discussions about a recent offering and its potential impact on investors, with some fearing dilution while others speculate about acquisitions. Community members are debating the company's cash position and the implications for future growth, including possible deals or expansion into new markets. Some are also following developments of the Solana meme coin $KIRK.X

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features. The company was founded by Alan R. Blackman and Barry B. Berler on December 16, 2017 and is headquartered in Melville, NY.

Sharps Technology Inc

STSS is trending due to a recent partnership with Pudgy Penguins to expand its Solana digital asset treasury exposure, sparking community discussions around valuation and potential short squeezes. The stock's low float and high short interest are fueling speculation about significant price movement, with community members actively mapping out potential short versus long battle zones. Community members are closely watching the company's ties to Solana and speculating on future price targets.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending due to discussions around a proposed offering of convertible senior notes, with some investors viewing it as a strategic move to boost cloud infrastructure and international commerce, while others express concern about potential dilution. The community is debating whether the offering is a sign of financial strength or weakness, and how it will impact the stock's price in the short and long term. Broader market sentiment towards Chinese stocks and their growth potential also contributes to the ongoing conversation.

Klarna Group Plc operates as an investment holding company. It provides an e-commerce payment solutions for merchants and shoppers. The firm connect an array of different financial services and commerce organizations, from PSPs, traditional banks, card networks and open banking providers, to commerce enablers, technology partners, in-store payments providers and shipping and return logistics providers. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending following its IPO, with the community actively discussing allocation sizes and potential shorting opportunities. Bullish sentiment is fueled by Klarna's growth and user base, while some express concerns around valuation and comparisons to competitors like Affirm. The stock's performance is being closely watched in light of recent IPO market dynamics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Predict a 51.26% Upside in Monopar Therapeutics (MNPR): Here's  What You Should Know

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics PR Newswire NORTH CHICAGO, Ill., Jan...

Up 1,000% in 2024, Wall Street Believes This Growth Stock Can Still Skyrocket

This biotech stock is a promising buy, but it does come with risks.

Monopar Therapeutics Inc. ($MNPR)Shares of Monopar skyrocketed over 350% by mid-day Thursday after the Wilmette, Illinois-based micro-cap biotech announced an agreement with AstraZeneca plc’s ($AZN) Alexion rare disease subsidiary to exclusively in-license the latter’s ALXN-1840.&nbsp;The drug candidate is a Phase 3 asset and is being investigated for treating Wilson disease, a&nbsp; rare and progressive genetic condition in which the body’s pathway for removing excess copper is compromised.&nbsp;The agreement calls upon Monopar paying an upfront cash payment and giving AstraZeneca an equity stake. The smaller biotech is also required to make regulatory and sales milestones-based future payments and royalties on future net sales.<figure class="image"><a href="https://stocktwits.com/symbol/MNPR"><img style="aspect-ratio:628/148;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/mnpr_sentiment_224afae297.png" alt="mnpr-sentiment.png" width="628" height="148"></a><figcaption>MNPR sentiment and message volume October 24, 2024, as of 2 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>Monopar said it will be responsible for all future development and commercialization activities.&nbsp;Energy Vault Holdings, Inc. ($NRGV)Retail sentiment toward Westlake Village, California-based Energy Vault contrasted the stock move on Thursday. The stock was down over 7% by mid-Thursday despite the lack of any major catalyst.&nbsp;On Monday, Energy Vault, a sustainable, grid-scale energy storage solutions provider, announced an agreement with Australian energy developer Enervest Group for the deployment of a 1,000 MWh battery energy storage in New South Wales, Australia.&nbsp;The stock jumped 25% over the next two sessions before pulling back.<figure class="image"><a href="https://stocktwits.com/symbol/NRGV"><img style="aspect-ratio:638/147;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/nrgv_sentiment_ad5ef0470a.png" alt="nrgv-sentiment.png" width="638" height="147"></a><figcaption>&nbsp;NRGV sentiment and message volume October 24, 2024, as of 2 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>On Stocktwits, retail sentiment was ‘extremely bullish’ (97/100) compared to the ‘neutral’ sentiment that prevailed on Wednesday.FREYR Battery, Inc. ($FREY)Luxembourg-headquartered FREYR, which manufactures lithium-ion batteries in its Norwegian facilities, has also found traction with retail investors.&nbsp;The green-energy company’s stock may have received a lift from the news that the European Union Innovation Fund has agreed to award 122 million-euro ($132.05 million) to develop its potential joint venture ‘Cathode Active Material’ manufacturing project in Vaasa, Finland.<figure class="image"><a href="https://stocktwits.com/symbol/FREY"><img style="aspect-ratio:637/145;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/frey_sentiment_6c4bdbd8f7.png" alt="frey-sentiment.png" width="637" height="145"></a><figcaption>FREY sentiment and message volume October 24, 2024, as of 2 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>The retail mood is exceedingly exuberant, with the sentiment score on Stocktwits at 97/100.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/quantumscape-stock-jumps-on-earnings-call-updates/cJ21uofR7Z">QuantumScape Stock Bounces Back After Earnings Call Boost, Tesla Tailwinds: Retail Turns Optimistic</a>For updates and corrections email newsroom@stocktwits.com&nbsp;

These 3 stocks have generated the most bullish sentiment among retailers Thursday afternoon.

Monopar Therapeutics, Energy Vault Holdings, FREYR Battery: 3 Stocks Retailers Are Most Bullish Thursday Afternoon

A micro-cap, clinical-stage biotech and two battery manufacturers elicited the most bullish reaction from retail traders.

Equity

A micro-cap, clinical-stage biotech and two battery manufacturers elicited the most bullish reaction from retail traders.


Monopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic Disorder

Monopar secures an exclusive license from AstraZeneca's Alexion for ALXN-1840, aiming to advance treatment for Wilson's disease, a rare genetic disorder.
read more...

Shares of Monopar Therapeutics, Inc. (<a class="mention" data-mention="$MNPR" data-symbol-id="MNPR" href="https://stocktwits.com/symbol/MNPR" target="_blank">$MNPR</a>) soared over 500% on Thursday following a major licensing agreement with AstraZeneca (<a class="mention" data-mention="$AZN" data-symbol-id="AZN" href="https://stocktwits.com/symbol/AZN" target="_blank">$AZN</a>) unit Alexion.&nbsp;The stock hit its highest levels since March 2021 and became the top gainer across U.S. exchanges, with retail sentiment surging into ‘extremely bullish’ territory.Monopar secured the rights to ALXN-1840, an oral treatment for Wilson’s disease, a rare genetic disorder that leads to toxic copper build-up in organs.&nbsp;The company will be responsible for all future global development and commercialization activities.In exchange, Monopar will pay an upfront sum in cash and equity, along with future royalties and milestone payments.&nbsp;Under Alexion’s prior development, ALXN-1840 had already met its primary endpoint in a Phase 3 clinical trial.On Stocktwits, retail sentiment for MNPR jumped to ‘extremely bullish’ (97/100), the highest score this year, driven by a surge in message volume as investors reacted to the breakthrough deal.&nbsp;<stembedurl>https://stocktwits.com/Krystian_v/message/589991504</stembedurl><stembedurl>https://stocktwits.com/Mosconi/message/589994892</stembedurl>Monpar stated that its MD, Co-Founder, and CEO, Chandler Robinson, previously conducted laboratory research on tetrathiomolybdate, published his findings in Science, and helped launch the company behind what became ALXN-1840. The focus was on Wilson disease.Wilson’s disease affects around 1 in 30,000 people in the U.S., causing excess copper to accumulate in the liver, brain, and other organs.&nbsp;The disease can lead to liver failure, neurological symptoms, and psychiatric issues, with many cases suffering irreversible damage.MNPR stock has now surged over 1,500% year-to-date.For updates and corrections email <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>Read next: <a href="https://stocktwits.com/news-articles/markets/equity/lilm-stock-crashes-after-insolvency-warning/cJ21sAxR7k">Air-Taxi Firm Lilium’s Stock Nosedives On Insolvency Warning: Retail Mood Darkens</a>

Monopar secured the rights to ALXN-1840, an oral treatment for Wilson’s disease, a rare genetic disorder that leads to toxic copper build-up in organs.

Monopar Stock Skyrockets After Agreement With AstraZeneca's Unit On Wilson's Disease Drug: Retail On Cloud Nine

The company will be responsible for all future global development and commercialization activities.

Monopar Stock Skyrockets After Agreement With AstraZeneca’s Unit On Wilson's Disease Drug: Retail On Cloud Nine

The company will be responsible for all future global development and commercialization activities.


Why Monopar Therapeutics (MNPR) Stock Is Skyrocketing Today

Monopar Therapeutics shares are trading higher by 108% Thursday morning. The company announced early Phase 1 trial data confirming MNPR-101-Zr's tumor-targeting ability in humans.
read more...

Monopar Therapeutics Inc: Positioned for Growth with Strategic Radiopharmaceutical Pivot and Promising Preclinical Data

JonesTrading analyst Justin Walsh reiterated a Buy rating on Monopar Therapeutics Inc (MNPR Research Report) today and set a price target of $2.0...

Monopar Therapeutics Begins Pioneering MNPR-101-Zr Trial

The latest announcement is out from Monopar Therapeutics Inc (MNPR). Monopar Therapeutics Inc. has reached a pivotal milestone by enrolling the fir...

Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying

Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.

Monopar Therapeutics Inc

Buying for a long-term investment

Buying for a short-term trade

Trading around the volatility

Avoiding it

$KLAR IPO day is upon us, how are you playing it?

Stocktwits

 IPO day is upon us, how are you playing it?

Current Price	$42.90
Prev Close	$44.93
Open	$43.56
Dividend Yield	0.00%
50-Day Moving Average	$38.66
Beta	0.88
Avg. Volume	33,896.67
PE Ratio	-11.68

52-Week High	$54.30
52-Week Low	$2.40
Market Capitalization	$277.22M
EPS (Annual)	-$4.11
Price to Book	5.27
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

MNPR
Monopar Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Latest MNPR News

MNPR Monopar Therapeutics Inc